IL-6 was shown to exacerbate MS inflammation, Thus, in a murine model of MS, the therapeutic effect of B cell depletion was indeed demonstrated to be mediated by ablation of IL-6 producing B cells36. This evidence concerns the gene IL6 and myeloid sarcoma.